Dublin, Feb. 25, 2019 (GLOBE NEWSWIRE) -- The "Near Infrared Imaging Market by Product Type (NIR Fluorescence Imaging, Reagents), Application (Cancer surgery, Plastic surgery, Gastrointestinal surgery) and End Users - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global near-infrared imaging market is valued at an estimated USD 416.3 million in 2018 and is projected to reach USD 822.4 million by 2023, at a CAGR of 14.6% during the forecast period.
Near-infrared (NIR) imaging is a technique which utilizes exogenous contrast agents, such as indocyanine green (ICG) as a tool for enhancing the visualization of vasculature and other biological structures during surgical procedures and in preclinical research.
Growth in the near-infrared imaging market can primarily be attributed to various factors such as the increasing number of global surgical procedures owing to the rising prevalence of target diseases and the advantages of NIR imaging over conventional visualization methods. The growth potential in emerging economies is expected to present market players with a wide range of opportunities.
On the other hand, the lengthy approval process which limits the availability of targeted fluorophores and the scarcity of trained professionals are expected to challenge market growth to a certain extent in the coming years.
The market is segmented based on product, application, end user, and region.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Near-Infrared Imaging: Market Overview
4.2 North American Near-Infrared Imaging Market, By Product, 2018 (USD Million)
4.3 Near-Infrared Imaging Market: Geographic Snapshot
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Global Surgical Procedures Owing to the Rising Prevalence of Target Diseases
5.2.1.2 Advantages of NIR Imaging Over Conventional Visualization Methods
5.2.2 Restraints
5.2.2.1 Lengthy Approval Process Limiting the Availability of Targeted Fluorophores
5.2.3 Opportunities:
5.2.3.1 Growth Potential in Emerging Economies
5.2.4 Challenges
5.2.4.1 Scarcity of Trained Professionals
6 Near-Infrared Imaging Market, By Product
6.1 Introduction
6.2 Devices
6.2.1 Near-Infrared Fluorescence Imaging Systems
6.2.1.1 Near-Infrared Fluorescence Imaging Systems to Account for the Larger Market Share
6.2.2 Near-Infrared Fluorescence & Bioluminescence Imaging Systems
6.2.2.1 Near-Infrared Fluorescence & Bioluminescence Imaging Systems Offer High Sensitivity and High Efficiency at A Relatively Low Cost
6.3 Reagents
6.3.1 Indocyanine Green (ICG)
6.3.1.1 Indocyanine Green Offers Higher Signal-To-Background Ratio Due to Lower Autofluorescence, Increased Tissue Penetration, and Greater Brightness
6.3.1.2 Other Reagents
7 Near-Infrared Imaging Market, By Application
7.1 Introduction
7.2 Preclinical Imaging
7.2.1 Increasing Research in the Fields of Cancer and Infectious & Vascular Diseases to Drive the Adoption of NIR Imaging Market for Preclinical Imaging
7.3 Cancer Surgeries
7.3.1 Rising Prevalence of Cancer to Drive Growth in the Cancer Surgeries Application Segment
7.4 Gastrointestinal Surgeries
7.4.1 Rising Number of Laparoscopic Cholecystectomy Procedures to Drive the NIR Imaging Market for Gastrointestinal Surgeries
7.5 Cardiovascular Surgeries
7.5.1 Rising Prevalence of Cardiovascular Diseases to Drive the Adoption of NIR Imaging for Cardiovascular Surgeries
7.6 Plastic/Reconstructive Surgeries
7.6.1 Increasing Number of Reconstructive Surgeries to Drive the Market Growth
7.7 Other Applications
8 Near-Infrared Imaging Market, By End User
8.1 Introduction
8.2 Hospitals & Clinics
8.2.1 Rising Number of Cancer Surgeries and Reconstructive Surgeries in Hospitals and Clinics to Drive Market Growth in This Segment
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 NIR Imaging Plays A Key Role in the Preclinical Research and Drug Discovery Processes in Pharmaceutical & Biotechnology Companies
8.4 Research Laboratories
8.4.1 Funding From Government Organizations for Biomedical Research to Drive the Adoption of NIR Imaging in Research Laboratories
9 Near-Infrared Imaging Market, By Region
10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Scenario
10.5 Competitive Scenario and Trends
10.5.1 Changing Competitive Landscape as Large Corporations Enter the NIR Imaging Market
10.5.2 Product Launches and Approvals
10.5.3 Expansions
10.5.4 Agreements, Collaborations, and Partnerships
10.5.5 Acquisitions
11 Company Profiles
11.1 Stryker
11.2 Karl Storz Se & Co.Kg
11.3 Carl Zeiss Meditech AG
11.4 Leica Microsystems (A Subsidiary of Danaher Corporation)
11.5 Olympus Corporation
11.6 Perkinelmer, Inc.
11.7 Li-Cor, Inc.
11.8 Hamamatsu Photonics K.K.
11.9 Quest Medical Imaging B.V.
11.10 Mizuho Medical Co., Ltd.
11.11 Fluoptics
11.12 Shimadzu Corporation
11.13 Medtronic
For more information about this report visit https://www.researchandmarkets.com/research/vs2kjp/global_822_4_mn?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Optical Sensors